Healthcare firm Sun Pharmaceutical Industries' revenues are seen going up by 46 percent YoY (of which 30.8% contribution by Taro) to Rs 2,764 crore in September quarter.
first published: Nov 8, 2012 02:05 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman

Budget 2026 expectations: Taxpayers eye higher standard deduction, home loan interest relief

Live: Will Nifty take a breather after 3-day rally amid mixed global cues | Opening Bell
You are already a Moneycontrol Pro user.